Výsledky vyhledávání - "K U, Birkenkamp"

The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway

Autor: K U, Birkenkamp, L M, Tuyt, C, Lummen, A T, Wierenga, W, Kruijer, E, Vellenga

Publikováno v: British journal of pharmacology. 131(1)

In the present study we investigated a possible role for the p38 mitogen-activated protein (MAP) kinase pathway in mediating nuclear factor-kappa B (NF-kappaB) transcriptional activity in the erythroleukaemic cell line TF-1. TF-1 cells stimulated wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5261d41d1c90323753d910f2e11a2bdc
https://pubmed.ncbi.nlm.nih.gov/10960075

Zobrazit plný text záznamu

Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5

Autor: K U, Birkenkamp, M T, Esselink, W, Kruijer, E, Vellenga

Publikováno v: European cytokine network. 10(4)

In the present study we examined whether the p38 and extracellular signal-regulated kinase (ERK) signal transduction pathways are involved in the interleukin-3 (IL-3)- or interleukin-1 (IL-1)-mediated proliferation and cytokine production of acute my

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ec6d9cd6f08d552674944f96247d6600
https://pubmed.ncbi.nlm.nih.gov/10586114

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání